Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Ebrahim S Delpassand"'
Autor:
Julien J. Torgue, Ebrahim S. Delpassand, Izabela Tworowska, Amal Saidi, Tania A. Rozgaja Stallons
Somatostatin analogues have been examined as a treatment for somatostatin receptor overexpressing tumors for years; specifically, octreotate (TATE) and octreotide (TOC). Several versions of these analogues coupled to beta or gamma nuclides are curren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01e6a724e74a057394756c3dcd33534f
https://doi.org/10.1158/1535-7163.c.6539611
https://doi.org/10.1158/1535-7163.c.6539611
Autor:
Julien J. Torgue, Ebrahim S. Delpassand, Izabela Tworowska, Amal Saidi, Tania A. Rozgaja Stallons
A biodistribution study was done in CD-1 non-tumor bearing mice to compare the male and female organ uptake of 212Pb-DOTAMTATE at 4hr and 24hr post drug injection. No significant difference is observed between the two sexes in all critical organs at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f2ba2608cdf1d0ef61c8d4881d85e36
https://doi.org/10.1158/1535-7163.22510417.v1
https://doi.org/10.1158/1535-7163.22510417.v1
Autor:
Ebrahim S. Delpassand, David Ranganathan, Ali Abbasi, Rodolfo Nunez, Nilesh K. Wagh, Ayman M. Gaber, A. Shafie, Izabela Tworowska
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:CLO20-034
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e628930094b93feb5120fdc125b94164
https://doi.org/10.6004/jnccn.2019.7422
https://doi.org/10.6004/jnccn.2019.7422
Autor:
Ayman M. Gaber, Rodolfo Nunez, Andreas Kjaer, Afshin Shafie, David Ranganathan, Ali Abbasi, Nilesh K. Wagh, Ebrahim S. Delpassand, Izabela Tworowska
Publikováno v:
Journal of Nuclear Medicine. 61:890-896
Studies demonstrate that the investigational 64Cu-DOTATATE radiopharmaceutical may provide diagnostic and logistical benefits over available imaging agents for patients with somatostatin receptor (SSTR)–positive neuroendocrine tumors (NETs). Accord
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b587d7f504b18994a9b4ea13dd1c8f94
https://doi.org/10.2967/jnumed.119.236091
https://doi.org/10.2967/jnumed.119.236091
Autor:
Nasim, Vahidfar, Saeed, Farzanehfar, Mehrshad, Abbasi, Siroos, Mirzaei, Ebrahim S, Delpassand, Farzad, Abbaspour, Yalda, Salehi, Hans Jürgen, Biersack, Hojjat, Ahmadzadehfar
Publikováno v:
Cancers. 14(8)
Neuroendocrine tumours (NETs) arise from secondary epithelial cell lines in the gastrointestinal or respiratory system organs. The rate of development of these tumours varies from an indolent to an aggressive course, typically being initially asympto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::44bbf2b8b41da3532fdd16516359458e
https://pubmed.ncbi.nlm.nih.gov/35454822
https://pubmed.ncbi.nlm.nih.gov/35454822
Autor:
Michael S Hofman, Johannes Czernin, Clemens Kratochwil, David Elashoff, Rouzbeh Esfandiari, Isabel Rauscher, Bjoern H. Menze, Ken Herrmann, Jeremie Calais, Hui Wang, Manuel Weber, Farid Yagubbayli, Wolfgang P. Fendler, Matthias Eiber, Ebrahim S. Delpassand, Andrei Gafita, Andrew Robertson, Wesley R Armstrong, Kathleen Nguyen, Tristan Grogan, Fernando Navarro, Raphael Zaum
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 63, iss 2
J Nucl Med
J Nucl Med
We aimed to systematically determine the impact of tumor burden on (68)Ga-prostate-specific membrane antigen-11 ((68)Ga-PSMA) PET biodistribution by the use of quantitative measurements. Methods: This international multicenter, retrospective analysis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b18a8a4391f84931b51e2a401daea842
https://escholarship.org/uc/item/3hp7t17v
https://escholarship.org/uc/item/3hp7t17v
Publikováno v:
Theranostics, Vol 2, Iss 1, Pp 472-480 (2012)
Aim: To study the long term benefits, toxicity and survival rate in patients with neuroendocrine tumors receiving multiple cycles of high activity In-111 Pentetreotide therapy. Moreover, our secondary aim was to evaluate the value of F-18 FDG PET-CT
Externí odkaz:
https://doaj.org/article/ebab49b9b94c4015878ea99119934b48
Autor:
Wolfgang P. Fendler, Shadfar Bahri, David Ranganathan, Jeannine Gartmann, Johannes Czernin, Jeremie Calais, Rouzbeh Esfandiari, Martin Allen-Auerbach, Pan Thin, Beilei He, Kathleen Nguyen, Linda Gardner, Wesley R Armstrong, Andrew Quon, Pawan Gupta, Ken Herrmann, Magnus Dahlbom, Ebrahim S. Delpassand, Matthias Eiber
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol 62, iss 10
The purpose of this analysis was to report the safety evaluation of 177Lu-PSMA-617 derived from the cohort of 64 patients exposed to 177Lu-PSMA-617 in the RESIST-PC trial NCT03042312. Methods: RESIST-PC was a prospective multicenter phase 2 trial. Pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f93c9519090ec3e7cb8a41201dd19de
https://escholarship.org/uc/item/3n3680n9
https://escholarship.org/uc/item/3n3680n9
Publikováno v:
Mol Cancer Ther
Somatostatin analogues have been examined as a treatment for somatostatin receptor overexpressing tumors for years; specifically, octreotate (TATE) and octreotide (TOC). Several versions of these analogues coupled to beta or gamma nuclides are curren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::776d71e86f2e8bdbb660755f7fe86b1c
https://doi.org/10.1158/1535-7163.mct-18-1103
https://doi.org/10.1158/1535-7163.mct-18-1103
Publikováno v:
The Egyptian Journal of Radiology and Nuclear Medicine, Vol 52, Iss 1, Pp 1-5 (2021)
Background 68Ga-PSMA-11 PET/CT is increasingly being used worldwide in prostate cancer patients. Accordingly, there is a pressing need for educational resources on the proper interpretation criteria that need to be used, including a deeper understand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec0e75708fa45519975fce613c262ca3
https://doi.org/10.1186/s43055-021-00518-w
https://doi.org/10.1186/s43055-021-00518-w